What’s Driving Oncology HTAs in South Korea?
Reimbursement in South Korea depends upon a favorable review by Health Insurance Review Agency (HIRA), and some therapies may not [...]
Policy Changes to Health Technology Assessment Process Reshape Market Access in South Korea
South Korea’s healthcare landscape has been constantly evolving since the passage of important legislation 20 years ago. However, concern remains [...]
Pharma14 adds South Korea to Global Medicine and Pricing Database
The pharmaceutical market in South Korea is undergoing rapid expansion and expected to reach more than US$ 21 billion by [...]
Advertisement
